Biblio

Author Title [ Type

] Year

Filters: Author is Falkenburg, J H Frederik [Clear All Filters]

Journal Article

van der Lee DI, Pont MJ, Falkenburg JHFrederik, Griffioen M. The Value of Online Algorithms to Predict T-Cell Ligands Created by Genetic Variants. PLoS One. 2016;11(9):e0162808.

Koster EAS, Borne PAVon Dem, van Balen P, Marijt EWA, Tjon JML, Snijders TJF, van Lammeren D, Veelken H, Falkenburg JHFrederik, Halkes CJM, et al. Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation. Front Immunol. 2024;15:1335341.

Pont MJ, Hobo W, Honders MW, van Luxemburg-Heijs SAP, Kester MGD, van Oeveren-Rietdijk AM, Schaap N, de Boer HC, van Bergen CAM, Dolstra H, et al. LB-ARHGDIB-1R as novel minor histocompatibility antigen for therapeutic application. Haematologica. 2015.

Koster EAS, Bonneville EF, Borne PA von dem, van Balen P, Marijt EWA, Tjon JML, Snijders TJF, van Lammeren D, Veelken H, Putter H, et al. Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion. Front Immunol. 2023;14:1208814.

Loeff FC, van Egmond EHM, Moes DJAR, Wijnands C, Borne PAVon Dem, Veelken H, Falkenburg JHFrederik, Jedema I, Halkes CJM. Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft. Transpl Immunol. 2019.

Hombrink P, Hassan C, Kester MGD, Jahn L, Pont MJ, de Ru AH, van Bergen CAM, Griffioen M, Falkenburg JHFrederik, van Veelen PA, et al. Identification of biological relevant minor histocompatibility antigens within the B-lymphocyte derived HLA-ligandome using a reverse immunology approach. Clin Cancer Res. 2015.

Fuchs KJ, van de Meent M, Honders MW, Khatri I, Kester MGD, Koster EAS, Koutsoumpli G, de Ru AH, van Bergen CAM, van Veelen PA, et al. Expanding the repertoire reveals recurrent, cryptic and hematopoietic HLA class I minor histocompatibility antigens. Blood. 2024.

van Bergen CAM, Verdegaal EME, M Honders W, Hoogstraten C, van Tol AQMJeanne, de Quartel L, de Jong J, Meyering M, Falkenburg JHFrederik, Griffioen M, et al. Durable Remission of Renal Cell Carcinoma in Conjuncture with Graft versus Host Disease following Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion: Rule or Exception?. PLoS One. 2014;9(1):e85198.

Koster EAS, Borne PAVon Dem, van Balen P, van Egmond EHM, Marijt EWA, Veld SAJ, Jedema I, Snijders TJF, van Lammeren D, Veelken H, et al. Competitive repopulation and allo-immunological pressure determine chimerism kinetics after T-cell depleted allogeneic stem cell transplantation and donor lymphocyte infusions. Transplant Cell Ther. 2022.